Advancing AI in Pharma
The International Society for Pharmaceutical Engineering (ISPE) has unveiled ISPE AI, a comprehensive initiative to help the pharmaceutical industry harness the power of artificial intelligence. This move signals ISPE’s commitment to supporting the industry’s AI readiness and responsible advancement. The initiative kicks off with the launch of the ISPE Community of Practice (CoP) on Artificial Intelligence, which is now open for ISPE members to join.
Key Components of the Initiative
- New AI Community of Practice (CoP) for ISPE members
- Future plans for AI-focused guidance documents, conference sessions, and training courses
- AI CoP Steering Committee to address regulatory aspects, implementation guidance, and organizational preparedness
- Building on existing ISPE efforts in digitalization and AI/machine learning
Shaping the Future of Pharma
This initiative underscores ISPE’s role as a trusted leader in the pharmaceutical industry. By providing a platform for sharing best practices, interfacing with regulatory authorities, and disseminating case studies, ISPE aims to inform effective AI strategy and implementation across the pharmaceutical lifecycle. The AI CoP joins ISPE’s existing 22 Global Technical CoPs, further expanding the organization’s support for critical industry developments. As AI continues to revolutionize the pharmaceutical sector, ISPE’s initiative promises to be a valuable resource for companies navigating this rapidly evolving landscape.
